|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Bay Lights Project Turns to Tech Leaders to Bridge Funding Gap
|
Wade Roush |
05/22/12 |
San Francisco
|
|
Yottaa, Looking More Like Akamai, Gets $9M for “Anti-Lean” Approach
|
Gregory T. Huang |
05/22/12 |
Boston
|
|
Bye, SocialEyes: Startup Drops Video Chat, Goes Mobile with Sidecar
|
Curt Woodward |
05/22/12 |
Seattle
|
|
Undaunted by Wall Street “Penalty Box,” Keryx Focuses on Kidney Drug
|
Arlene Weintraub |
05/22/12 |
New York
|
|
Wireless Health Summit Showcases Incentive Prizes as Tool for Change
|
Bruce V. Bigelow |
05/21/12 |
San Diego
|
|
Ember CEO: Silicon Labs Acquisition for $72M Is “Right Thing for the Company”
|
Gregory T. Huang |
05/21/12 |
Boston
|
|
Google Makes Room for Cornell Engineering Campus at its NY Offices
|
João-Pierre S. Ruth |
05/21/12 |
New York
|
|
99designs Crowdsources Its Own New Website Design
|
Elise Craig |
05/21/12 |
San Francisco
|
|
DIYer’s Delight: Video from Maker Faire 2012
|
Wade Roush |
05/21/12 |
San Francisco
|
|
Sue Siegel Leaves MDV to Run $6B GE Health Unit
|
Luke Timmerman |
05/21/12 |
San Francisco
|
|
Why Facebook Is Killing Silicon Valley
|
Steve Blank |
05/21/12 |
San Francisco
|
|
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration
|
Luke Timmerman |
05/21/12 |
San Francisco
|
|
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers
|
Luke Timmerman |
05/21/12 |
National
|
|
NeighborPower Brings Rewards Points to the Energy Market
|
Erin Kutz |
05/21/12 |
Boston
|
|
Will 3-D Thermal Imaging Revolutionize Breast Cancer Detection?
|
Sarah Schmid |
05/18/12 |
Detroit
|
|
Misery Loves Company: 38 Studios, AEB, and WFNX
|
Gregory T. Huang |
05/18/12 |
Boston
|
|
Can Facebook’s New Millionaires Save the World?
|
Wade Roush |
05/18/12 |
National
|
|
For Those on Watch, Hope Springs Eternal as Hair Trials Inch Along
|
Bruce V. Bigelow |
05/18/12 |
San Diego
|
|
CardioKinetix Clears 2-Year Study with Implant for Heart Failure
|
Luke Timmerman |
05/18/12 |
San Francisco
|
|
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines
|
Erin Kutz |
05/18/12 |
Boston
|
|
Does Facebook Solve VC Industry Woes?
|
Michael A. Greeley |
05/17/12 |
Boston
|
|
Think Tech Labs Tailors Salesforce to the Real Estate Market
|
Sarah Schmid |
05/17/12 |
Detroit
|
|
From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
|
Gregory T. Huang |
05/17/12 |
Boston
|
|
SD Biotech Roundup: Elevation Pharmaceuticals, BioSurplus, and More
|
Bruce V. Bigelow |
05/17/12 |
San Diego
|
|
Xconomist of the Week: Tom Maniatis on Prize4Life and ALS Research
|
Arlene Weintraub |
05/17/12 |
National
|
|
Investors Talk Disruption in Digital Music at Internet Week New York
|
João-Pierre S. Ruth |
05/17/12 |
New York
|
|
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say
|
Luke Timmerman |
05/16/12 |
Seattle
|
|
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study
|
Luke Timmerman |
05/16/12 |
Boston
|
|
Quirks & Perqs: YC Startups Woo Employees with Unusual Benefits
|
Wade Roush |
05/16/12 |
San Francisco
|
|
CloudTop, Ketchup, Todd Park, & A New President: An MIT Recap
|
Erin Kutz |
05/16/12 |
Boston
|
|
Page 2 of
441 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.